These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38852834)

  • 1. Spinal cord injury-induced metabolic impairment and steatohepatitis develops in non-obese rats and is exacerbated by premorbid obesity.
    Goodus MT; Alfredo AN; Carson KE; Dey P; Pukos N; Schwab JM; Popovich PG; Gao J; Mo X; Bruno RS; McTigue DM
    Exp Neurol; 2024 Sep; 379():114847. PubMed ID: 38852834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver inflammation at the time of spinal cord injury enhances intraspinal pathology, liver injury, metabolic syndrome and locomotor deficits.
    Goodus MT; Carson KE; Sauerbeck AD; Dey P; Alfredo AN; Popovich PG; Bruno RS; McTigue DM
    Exp Neurol; 2021 Aug; 342():113725. PubMed ID: 33933462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Green Tea Extract Prior to Spinal Cord Injury Prevents Hepatic Iron Overload but Does Not Improve Chronic Hepatic and Spinal Cord Pathology in Rats.
    Goodus MT; Sauerbeck AD; Popovich PG; Bruno RS; McTigue DM
    J Neurotrauma; 2018 Dec; 35(24):2872-2882. PubMed ID: 30084733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
    Patton HM; Yates K; Unalp-Arida A; Behling CA; Huang TT; Rosenthal P; Sanyal AJ; Schwimmer JB; Lavine JE
    Am J Gastroenterol; 2010 Sep; 105(9):2093-102. PubMed ID: 20372110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology?
    Goodus MT; McTigue DM
    Exp Neurol; 2020 Mar; 325():113160. PubMed ID: 31863731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal cord injury causes chronic liver pathology in rats.
    Sauerbeck AD; Laws JL; Bandaru VV; Popovich PG; Haughey NJ; McTigue DM
    J Neurotrauma; 2015 Feb; 32(3):159-69. PubMed ID: 25036371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waist circumference cutoff identifying risks of obesity, metabolic syndrome, and cardiovascular disease in men with spinal cord injury.
    Gill S; Sumrell RM; Sima A; Cifu DX; Gorgey AS
    PLoS One; 2020; 15(7):e0236752. PubMed ID: 32726371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome is the key determinant of impaired vaginal lubrication in women with chronic spinal cord injury.
    D'Andrea S; Castellini C; Paladino V; Totaro M; Felzani G; Francavilla S; Francavilla F; Barbonetti A
    J Endocrinol Invest; 2020 Jul; 43(7):1001-1007. PubMed ID: 31983040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects.
    Huang HL; Lin WY; Lee LT; Wang HH; Lee WJ; Huang KC
    Obes Surg; 2007 Nov; 17(11):1457-63. PubMed ID: 18219772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.
    Subramanian S; Goodspeed L; Wang S; Kim J; Zeng L; Ioannou GN; Haigh WG; Yeh MM; Kowdley KV; O'Brien KD; Pennathur S; Chait A
    J Lipid Res; 2011 Sep; 52(9):1626-35. PubMed ID: 21690266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis.
    Li ZL; Woollard JR; Ebrahimi B; Crane JA; Jordan KL; Lerman A; Wang SM; Lerman LO
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1132-41. PubMed ID: 22383702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet modification and its influence on metabolic and related pathological alterations in the SHR/NDmcr-cp rat, an animal model of the metabolic syndrome.
    Kawai K; Sakairi T; Harada S; Shinozuka J; Ide M; Sato H; Tanaka M; Toriumi W; Kume E
    Exp Toxicol Pathol; 2012 May; 64(4):333-8. PubMed ID: 20965707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome in adolescents with spinal cord dysfunction.
    Nelson MD; Widman LM; Abresch RT; Stanhope K; Havel PJ; Styne DM; McDonald CM
    J Spinal Cord Med; 2007; 30 Suppl 1(Suppl 1):S127-39. PubMed ID: 17874698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.
    Li S; Liao X; Meng F; Wang Y; Sun Z; Guo F; Li X; Meng M; Li Y; Sun C
    PLoS One; 2014; 9(1):e86724. PubMed ID: 24489777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling.
    Clementi AH; Gaudy AM; van Rooijen N; Pierce RH; Mooney RA
    Biochim Biophys Acta; 2009 Nov; 1792(11):1062-72. PubMed ID: 19699298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity.
    Drager LF; Li J; Reinke C; Bevans-Fonti S; Jun JC; Polotsky VY
    Obesity (Silver Spring); 2011 Nov; 19(11):2167-74. PubMed ID: 21799478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats.
    Nakano T; Cheng YF; Lai CY; Hsu LW; Chang YC; Deng JY; Huang YZ; Honda H; Chen KD; Wang CC; Chiu KW; Jawan B; Eng HL; Goto S; Chen CL
    J Hepatol; 2011 Aug; 55(2):415-25. PubMed ID: 21184788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
    Walle P; Takkunen M; Männistö V; Vaittinen M; Lankinen M; Kärjä V; Käkelä P; Ågren J; Tiainen M; Schwab U; Kuusisto J; Laakso M; Pihlajamäki J
    Metabolism; 2016 May; 65(5):655-666. PubMed ID: 27085774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.